Dermata Therapeutics Stock Price History
DRMA Stock | USD 1.08 0.04 3.57% |
If you're considering investing in Dermata Stock, it is important to understand the factors that can impact its price. As of today, the current price of Dermata Therapeutics stands at 1.08, as last reported on the 19th of November, with the highest price reaching 1.11 and the lowest price hitting 1.05 during the day. Dermata Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0719, which denotes the company had a -0.0719% return per unit of risk over the last 3 months. Dermata Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dermata Therapeutics' Standard Deviation of 8.41, mean deviation of 5.17, and Variance of 70.73 to check the risk estimate we provide.
At present, Dermata Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to 655.46, whereas Common Stock Shares Outstanding is forecasted to decline to about 185.2 K. . At present, Dermata Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.29, whereas Price Earnings Ratio is forecasted to decline to (0.24). Dermata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Dermata |
Sharpe Ratio = -0.0719
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | DRMA |
Estimated Market Risk
8.47 actual daily | 75 75% of assets are less volatile |
Expected Return
-0.61 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dermata Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dermata Therapeutics by adding Dermata Therapeutics to a well-diversified portfolio.
Price Book 0.5098 | Book Value 24.251 | Enterprise Value -3.9 M | Enterprise Value Ebitda 0.5842 | Shares Float 1.3 M |
Dermata Therapeutics Stock Price History Chart
There are several ways to analyze Dermata Stock price data. The simplest method is using a basic Dermata candlestick price chart, which shows Dermata Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 16, 2024 | 2.32 |
Lowest Price | November 18, 2024 | 1.08 |
Dermata Therapeutics November 19, 2024 Stock Price Synopsis
Various analyses of Dermata Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Dermata Stock. It can be used to describe the percentage change in the price of Dermata Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Dermata Stock.Dermata Therapeutics Price Daily Balance Of Power | (0.67) | |
Dermata Therapeutics Price Action Indicator | (0.02) | |
Dermata Therapeutics Price Rate Of Daily Change | 0.96 |
Dermata Therapeutics November 19, 2024 Stock Price Analysis
Dermata Stock Price History Data
The price series of Dermata Therapeutics for the period between Wed, Aug 21, 2024 and Tue, Nov 19, 2024 has a statistical range of 1.24 with a coefficient of variation of 17.0. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.54. The median price for the last 90 days is 1.51. The company completed 1:15 stock split on 16th of May 2024.Open | High | Low | Close | Volume | ||
11/19/2024 | 1.11 | 1.11 | 1.05 | 1.08 | ||
11/18/2024 | 1.11 | 1.11 | 1.05 | 1.08 | 51,123 | |
11/15/2024 | 1.19 | 1.21 | 1.11 | 1.12 | 74,602 | |
11/14/2024 | 1.23 | 1.29 | 1.15 | 1.19 | 58,382 | |
11/13/2024 | 1.30 | 1.30 | 1.23 | 1.23 | 50,169 | |
11/12/2024 | 1.38 | 1.38 | 1.25 | 1.29 | 45,103 | |
11/11/2024 | 1.39 | 1.42 | 1.26 | 1.35 | 78,073 | |
11/08/2024 | 1.32 | 1.54 | 1.32 | 1.39 | 216,607 | |
11/07/2024 | 1.36 | 1.41 | 1.34 | 1.34 | 58,137 | |
11/06/2024 | 1.30 | 1.42 | 1.29 | 1.35 | 87,831 | |
11/05/2024 | 1.20 | 1.29 | 1.20 | 1.29 | 47,617 | |
11/04/2024 | 1.25 | 1.25 | 1.20 | 1.22 | 31,266 | |
11/01/2024 | 1.30 | 1.32 | 1.22 | 1.23 | 37,771 | |
10/31/2024 | 1.31 | 1.38 | 1.25 | 1.27 | 97,688 | |
10/30/2024 | 1.39 | 1.46 | 1.31 | 1.35 | 81,064 | |
10/29/2024 | 1.42 | 1.48 | 1.38 | 1.39 | 34,720 | |
10/28/2024 | 1.49 | 1.51 | 1.40 | 1.46 | 67,214 | |
10/25/2024 | 1.40 | 1.55 | 1.36 | 1.49 | 235,069 | |
10/24/2024 | 1.45 | 1.45 | 1.36 | 1.38 | 87,793 | |
10/23/2024 | 1.61 | 1.62 | 1.43 | 1.45 | 88,979 | |
10/22/2024 | 1.53 | 1.62 | 1.50 | 1.57 | 86,308 | |
10/21/2024 | 1.51 | 1.63 | 1.51 | 1.56 | 137,336 | |
10/18/2024 | 1.53 | 1.68 | 1.41 | 1.61 | 342,508 | |
10/17/2024 | 1.31 | 1.59 | 1.31 | 1.58 | 1,792,434 | |
10/16/2024 | 1.30 | 1.50 | 1.30 | 1.33 | 276,082 | |
10/15/2024 | 1.28 | 1.38 | 1.25 | 1.29 | 166,394 | |
10/14/2024 | 1.35 | 1.35 | 1.22 | 1.29 | 67,081 | |
10/11/2024 | 1.31 | 1.38 | 1.31 | 1.35 | 28,262 | |
10/10/2024 | 1.36 | 1.43 | 1.32 | 1.34 | 51,588 | |
10/09/2024 | 1.34 | 1.38 | 1.31 | 1.36 | 35,869 | |
10/08/2024 | 1.33 | 1.38 | 1.30 | 1.37 | 48,924 | |
10/07/2024 | 1.43 | 1.43 | 1.31 | 1.33 | 78,789 | |
10/04/2024 | 1.44 | 1.47 | 1.40 | 1.42 | 23,625 | |
10/03/2024 | 1.48 | 1.53 | 1.38 | 1.43 | 95,908 | |
10/02/2024 | 1.50 | 1.50 | 1.43 | 1.49 | 61,830 | |
10/01/2024 | 1.59 | 1.66 | 1.46 | 1.53 | 163,891 | |
09/30/2024 | 1.59 | 1.69 | 1.56 | 1.64 | 199,590 | |
09/27/2024 | 1.56 | 1.62 | 1.50 | 1.56 | 159,252 | |
09/26/2024 | 1.56 | 1.60 | 1.49 | 1.55 | 48,280 | |
09/25/2024 | 1.50 | 1.63 | 1.50 | 1.55 | 187,879 | |
09/24/2024 | 1.63 | 1.63 | 1.48 | 1.50 | 136,138 | |
09/23/2024 | 1.82 | 1.82 | 1.61 | 1.62 | 90,420 | |
09/20/2024 | 1.78 | 1.84 | 1.76 | 1.78 | 100,984 | |
09/19/2024 | 2.28 | 2.30 | 1.75 | 1.75 | 482,767 | |
09/18/2024 | 1.93 | 2.38 | 1.93 | 2.25 | 612,966 | |
09/17/2024 | 2.11 | 2.27 | 1.95 | 2.06 | 952,522 | |
09/16/2024 | 2.38 | 2.49 | 1.86 | 2.32 | 24,224,045 | |
09/13/2024 | 1.50 | 1.74 | 1.49 | 1.58 | 184,539 | |
09/12/2024 | 1.60 | 1.60 | 1.42 | 1.45 | 42,800 | |
09/11/2024 | 1.62 | 1.62 | 1.55 | 1.57 | 27,226 | |
09/10/2024 | 1.63 | 1.63 | 1.53 | 1.61 | 52,791 | |
09/09/2024 | 1.58 | 1.65 | 1.51 | 1.63 | 32,979 | |
09/06/2024 | 1.43 | 1.64 | 1.43 | 1.58 | 63,102 | |
09/05/2024 | 1.55 | 1.55 | 1.35 | 1.43 | 136,710 | |
09/04/2024 | 1.61 | 1.61 | 1.48 | 1.51 | 94,811 | |
09/03/2024 | 1.71 | 1.71 | 1.59 | 1.60 | 41,560 | |
08/30/2024 | 1.76 | 1.80 | 1.71 | 1.74 | 88,913 | |
08/29/2024 | 1.74 | 1.89 | 1.71 | 1.72 | 96,766 | |
08/28/2024 | 1.76 | 1.83 | 1.71 | 1.77 | 223,932 | |
08/27/2024 | 1.73 | 1.77 | 1.67 | 1.75 | 97,152 | |
08/26/2024 | 1.80 | 1.88 | 1.67 | 1.69 | 82,845 |
About Dermata Therapeutics Stock history
Dermata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dermata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dermata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dermata Therapeutics stock prices may prove useful in developing a viable investing in Dermata Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 195 K | 185.2 K | |
Net Loss | -8.6 M | -9.1 M |
Dermata Therapeutics Stock Technical Analysis
Dermata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
All Next | Launch Module |
Dermata Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dermata Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Dermata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dermata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.77) | |||
Total Risk Alpha | (1.61) | |||
Treynor Ratio | (0.32) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Dermata Stock analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |